CSL warns of lower profit

Chairman says profit likely to grow less than forecast if US court case settled.

CSL (CSL) says its net profit is likely to grow less than forecast if a court settlement in the United States is approved.

At 1115 AEDT, shares in CSL were 1.25% higher at $66.195, against a slight benchmark index lift of 0.06%.

Chairman John Shine told the group's annual general meeting that although fiscal 2014 net profit was forecast to grow 10%, settlement of the court case would represent a one-off charge reducing net profit by $US39 million ($41.2 million), reducing profit growth to 7%.

The outlook is subject to a number of other variables, Mr Shine said. 

CSL has signed an agreement to settle US antitrust class action litigation filed by American and Puerto Rican hospital groups which has been ongoing since 2009.

The settlement includes a $US64 million payment and is subject to US Federal Court approval.

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles